Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             106 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Author Index 2019
 29 S2 p. I-IV
 artikel
2 Content 2019
 29 S2 p. iii-vii
 artikel
3 Editorial Board 2019
 29 S2 p. IFC
 artikel
4 Keyword Index 2019
 29 S2 p. V
 artikel
5 P.2.30 Agomelatine restores home cage activity and sleep/wake disturbances in a model of melatonin deficiency Ivanova, N.
 2019
 29 S2 p. S676
 artikel
6 P.1.19 A homozygous missense mutation in SLC7A5 leads to autism spectrum disorder and microcephaly Knaus, L.
 2019
 29 S2 p. S647
 artikel
7 P.1.08 Alterations in α2A-adrenoceptor mediated G-protein signalling in postmortem prefrontal cortex of schizophrenia subjects Mosquera, I. Brocos
 2019
 29 S2 p. S638-S639
 artikel
8 P.2.16 Altered anatomical network correlates of cognitive function in bipolar disorder Mcphilemy, G.
 2019
 29 S2 p. S666-S667
 artikel
9 P.3.20 Analysis of pharmacological response to selective serotonin reuptake inhibitors using functional MRI and gene expression Reed, M.B.
 2019
 29 S2 p. S694
 artikel
10 P.4.14 An investigation of retinal layer thicknesses in unaffected first degree relatives of schizophrenia patients Kurtulmus, A.
 2019
 29 S2 p. S711-S712
 artikel
11 P.4.02 Apolipoprotein E genotype and cortical structure: global deterioration in non-demented, young to mid-age ε4 homozygotes Goltermann, J.
 2019
 29 S2 p. S701-S702
 artikel
12 P.1.29 Are schizophrenia and bipolar polygenic risk scores associated with positive and manic symptoms at psychosis onset? Quattrone, D.
 2019
 29 S2 p. S654
 artikel
13 P.2.05 Autistic-like symptoms revealed in female rats prenatally exposed to valproic acid following a viral immune challenge Thornton, A.
 2019
 29 S2 p. S658
 artikel
14 P.2.02 Bottom-up versus top-down attention during working memory encoding: A functional magnetic resonance imaging study Qubad, M.
 2019
 29 S2 p. S655-S656
 artikel
15 P.2.24 Brain and behavioural changes in mice colonized with human ADHD gut microbiota Dam, S.
 2019
 29 S2 p. S671-S672
 artikel
16 P.1.17 Brain metabolome during anesthesia – similarities and differences between post-ictal state Kohtala, S.
 2019
 29 S2 p. S645-S646
 artikel
17 P.3.14 Brain structural correlates of insomnia severity in major depressive disorder: Results from the ENIGMA-MDD consortium Leerssen, J.
 2019
 29 S2 p. S688-S690
 artikel
18 P.4.11 Bumetanide in Autism Medication and Biomarker (BAMBI) study: Medication response profiles Sprengers, J.
 2019
 29 S2 p. S708-S709
 artikel
19 P.3.22 Can we assess cognition and functional capacity simultaneously? Validation of a virtual reality shopping task Porffy, L.
 2019
 29 S2 p. S695-S696
 artikel
20 P.2.14 Characterisation of a new model of frontotemporal dementia for neuroprotective studies with cannabinoids Sanz, I. Santos-García
 2019
 29 S2 p. S664-S665
 artikel
21 P.1.03 Characterisation of the splice isoform profile of the calcium channel gene CACNA1C in human brain Hall, N.
 2019
 29 S2 p. S634
 artikel
22 P.1.24 Characterising the transcriptional profile of bipolar disorder risk gene CACNA1C Husain, S.M.
 2019
 29 S2 p. S650-S651
 artikel
23 P.3.12 Childhood trauma and social cognition in schizophrenia Rokita, K.
 2019
 29 S2 p. S687-S688
 artikel
24 P.4.12 Classification of mood disorders using a multiple kernel approach on multimodal neuroimaging data Bertocchi, C.
 2019
 29 S2 p. S709-S710
 artikel
25 P.2.29 Comfort for the troubled mind: A neural mechanism of stress feeding Linders, L.
 2019
 29 S2 p. S675-S676
 artikel
26 P.2.23 Components of reward processing and their association with the use of different cannabis types Craft, S.
 2019
 29 S2 p. S671
 artikel
27 P.4.09 Corticolimbic connectivity mediates the early stress - suicidality relation in 5-HTTLPR S-carrier bipolar depression Mascia, M.
 2019
 29 S2 p. S707
 artikel
28 P.4.01 C-X-C chemokine signalling is implicated in major depressive disorder in a sample of Korean elderly subjects Fanelli, G.
 2019
 29 S2 p. S701
 artikel
29 P.3.04 Deciphering polygenic risk for inflammation and depressive symptoms: A two-sample network analysis approach Kappelmann, N.
 2019
 29 S2 p. S680-S681
 artikel
30 P.2.07 Differential effects of psychotropic drugs on microbiome composition Cussotto, S.
 2019
 29 S2 p. S659-S660
 artikel
31 P.2.06 Differential role of GABAergic alterations in the dorsal and ventral dentate gyrus, and its impact on childhood stress Tripathi, K.
 2019
 29 S2 p. S658-S659
 artikel
32 P.3.23 Disrupted connectivity of the locus coeruleus in healthy adults with parental history of Alzheimer's disease Cerro, I. Del
 2019
 29 S2 p. S696-S697
 artikel
33 P.3.16 DNA methylation at the myelin basic protein gene - susceptibility to prenatal stress in mouse and man Weidner, M.
 2019
 29 S2 p. S690-S691
 artikel
34 P.4.04 Effectiveness of the pharmacological approcah in preventing post-stroke depression Morariu, E.A.
 2019
 29 S2 p. S703-S704
 artikel
35 P.2.18 Effect of maternal immune activation on the excitability of monoamine neurons in the offspring Csatlósová, K.
 2019
 29 S2 p. S668
 artikel
36 P.1.20 Effects of agmatine on Akt/GSK-3beta/beta-catenin signaling pathway in SH-SY5Y cell culture: Relevance to schizophrenia Unal, G.
 2019
 29 S2 p. S647-S648
 artikel
37 P.1.25 Effects of antipsychotic treatment on GABA-A receptor function Peris, A.
 2019
 29 S2 p. S651
 artikel
38 P.2.19 Effects of clonidine on MMN and P3a amplitude in schizophrenia patients on stable medication Kruiper, C.
 2019
 29 S2 p. S668-S669
 artikel
39 P.2.26 Effects of excessive substance use on inhibitory control in patients with attention-deficit/hyperactivity disorder Paraskevopoulou, M.
 2019
 29 S2 p. S673-S674
 artikel
40 P.3.26 Effects of hydrocortisone on cognitive performance and threat-interference under acute stress in highly anxious females. Angelidis, A.
 2019
 29 S2 p. S698-S699
 artikel
41 P.4.05 Entering the new era of cognitive scoring? Eye-tracking assessment of neurodegenerative disorders. Podlasek, A.
 2019
 29 S2 p. S704
 artikel
42 P.3.08 Event-related potentials in human nucleus accumbens reflect response inhibition success Eijsker, N.
 2019
 29 S2 p. S684-S685
 artikel
43 P.4.13 Exploring neurocognitive mechanisms underlying losartan-augmented prevention of posttraumatic stress symptom development Shkreli, L.
 2019
 29 S2 p. S710-S711
 artikel
44 P.1.18 Exposure to air pollution constituents alters locomotor behaviour and evokes inflammatory response in mice Jankowska, M.
 2019
 29 S2 p. S646-S647
 artikel
45 P.1.04 Expression of histone variants H3.3 and H2a.z in the rat brain: Physiopathological and pharmacological implications Radighieri, G.
 2019
 29 S2 p. S635
 artikel
46 P.2.22 Finding new secretomes for Parkinson's disease regenerative medicine applications Domingues, V.
 2019
 29 S2 p. S670-S671
 artikel
47 P.1.26 Glucocorticoid receptor deletion in microglia affects neurogenesis and inflammation in a mouse model of depression Abdallah, F.
 2019
 29 S2 p. S652
 artikel
48 P.2.13 High reproducibility across sites in a pre-clinical study through a coordinated behavioural and pharmacological protocol Araujo, M. Arroyo
 2019
 29 S2 p. S664
 artikel
49 P.2.10 Hippocampal Cx43 hemichannel inactivation protects from glutamatergic stress-related behaviour Portal, B.
 2019
 29 S2 p. S661-S662
 artikel
50 P.1.16 Impact of type 2 diabetes-associated mood disorders on the electrical properties of brain serotoninergic neurons Martin, H.
 2019
 29 S2 p. S644-S645
 artikel
51 P.1.15 Impaired diacylglycerol kinase eta function in bipolar patient-derived human induced pluripotent stem cells Mcneill, R.
 2019
 29 S2 p. S644
 artikel
52 P.1.23 Implication of Rab35/ESCRT pathway in tau proteostasis under control and pathological conditions Gomes, P.
 2019
 29 S2 p. S649-S650
 artikel
53 P.2.08 Increased sensitivity to Δ9-tetrahydrocannabinol and MDMA reward after exposure to nicotine in mice and zebrafish Ponzoni, L.
 2019
 29 S2 p. S660
 artikel
54 P.3.28 Individual prediction of electroconvulsive therapy response using multicenter neuroimaging data: For GEMRIC consortium Bruin, W.
 2019
 29 S2 p. S700
 artikel
55 P.1.11 Inflammatory markers in anorexia nervosa: An exploratory study Dalton, B.
 2019
 29 S2 p. S640-S641
 artikel
56 P.2.27 Influence of a novel G protein-biased opioid, PZM21, on behavioural effects of morphine in mice Kudla, L.
 2019
 29 S2 p. S674
 artikel
57 P.1.12 Intellectual disability-related genes increase ADHD risk and locomotor activity in Drosophila melanogaster Klein, M.
 2019
 29 S2 p. S641-S642
 artikel
58 P.1.10 Long-term down-regulation of BDNF in association with exposure to stress early in life: The role of miR-583 Zonca, V.
 2019
 29 S2 p. S639-S640
 artikel
59 P.2.17 Low cholesterol levels and inferior family environment in children predict impulsivity in young adulthood Tomson-Johanson, K.
 2019
 29 S2 p. S667
 artikel
60 P.4.08 Metabolic syndrome, inflammation and oxidative stress as potential risk factors for affective disorders – a twin study Ottesen, N.M.
 2019
 29 S2 p. S706-S707
 artikel
61 P.2.01 Metoclopramide inhibits trigemino-durovascular nociception: Implication for migraine Dolgorukova, A.
 2019
 29 S2 p. S655
 artikel
62 P.2.28 Mutual activation of muscarinic and mGlu2 receptors as a new treatment of schizophrenia-related cognitive deficits Cieślik, P.
 2019
 29 S2 p. S675
 artikel
63 P.3.18 Neurohormonal and neurotropic effects of Vitamin D3 in the middle-aged female rats at 12 weeks after ovariectomy Romanov, V.
 2019
 29 S2 p. S692-S693
 artikel
64 P.2.20 Neuropeptide Y in the dorsal dentate gyrus is an important protective factor that mediate trauma resilience Tsur, S. Regev
 2019
 29 S2 p. S669-S670
 artikel
65 P.1.13 Neuroplastic changes following chronic treatment with antipsychotic blonanserin in rats: Implications for schizophrenia Marchisella, F.
 2019
 29 S2 p. S642-S643
 artikel
66 P.1.28 NMDA receptor subunit composition shift in the SNr in experimental parkinsonism Sitzia, G.
 2019
 29 S2 p. S653-S654
 artikel
67 P.1.07 N-methyl-D-aspartate receptor encephalitis versus schizophrenia: A comparative brain imaging study using MR spectroscopy Bruns, M. Masias
 2019
 29 S2 p. S637-S638
 artikel
68 P.3.25 No evidence for antidepressant-like acute effects of bright light on behavioural measures of affective processing Kaltenboeck, A.
 2019
 29 S2 p. S698
 artikel
69 P.4.10 Obesity, first-episode psychosis and lower brain gray matter volumes Kolenic, M.
 2019
 29 S2 p. S708
 artikel
70 P.1.14 Oxytocin receptor gene methylation as a molecular marker for severity of depressive symptoms in mood disorder patients Ludwig, B.
 2019
 29 S2 p. S643-S644
 artikel
71 P.1.05 Parcellation of the cerebral cortex based on messenger ribonucleic acid gene expressions Murgaš, M.
 2019
 29 S2 p. S635-S636
 artikel
72 P.3.06 Predicting antidepressant treatment response from functional connectivity Klöbl, M.
 2019
 29 S2 p. S682-S683
 artikel
73 P.4.07 Prenatal therapy with a BDNF mimetic elicits a widespread rescue of neurogenesis in a mouse model of Down syndrome Uguagliati, B.
 2019
 29 S2 p. S705-S706
 artikel
74 P.3.11 Quality of sleep in relation to socio-demographic and clinical characteristics of the neuromuscular disease Arandjelovic, J.
 2019
 29 S2 p. S686-S687
 artikel
75 P.1.02 Role of miR-19 in the vulnerability or resilience to stress-related disorders: Novel target for preventive strategies Cattane, N.
 2019
 29 S2 p. S633-S634
 artikel
76 P.3.17 Searching for clinical and radiological predictors of response to INF-Beta therapy in patients with multiple sclerosis Zacharzewska-Gondek, A.
 2019
 29 S2 p. S691-S692
 artikel
77 P.1.21 Selective regulation of cb1 and d2 receptor genes transcription by perinatal delta-9-tetrahydrocannabinol exposure Bartolomeo, M. Di
 2019
 29 S2 p. S648-S649
 artikel
78 P.2.09 Sensory processing sensitivity and its association with seasonal affective disorder Hjordt, L.V.
 2019
 29 S2 p. S660-S661
 artikel
79 P.2.03 Stress changes amphetamine response and D2 receptor expression parallelly with epigenetic regulation in low-anxiety rats Kolosowska, K.
 2019
 29 S2 p. S656-S657
 artikel
80 P.3.24 Structural magnetic resonance imaging markers are associated with Alzheimer's disease pathway-specific polygenic scores Harrison, J.
 2019
 29 S2 p. S697
 artikel
81 P.1.09 Subtypes and interneuron function of somatostatin-expressing neurons in mouse reward region, the ventral tegmental area Nagaeva, E.
 2019
 29 S2 p. S639
 artikel
82 P.3.09 Systematic review and meta-analysis of lithium safety and efficacy in pregnancy and peri-partum Solmi, M.
 2019
 29 S2 p. S685
 artikel
83 P.3.07 Targeting emotional dysregulation in adult attention-deficit hyperactivity disorder Kaiser, A.
 2019
 29 S2 p. S683-S684
 artikel
84 P.3.03 The acute effects of cannabidiol on emotional processing and anxiety: A neurocognitive imaging study Yamamori, Y.
 2019
 29 S2 p. S680
 artikel
85 P.4.03 The acute effects of cannabidiol on reward processing in humans: an fMRI study Yim, J.L.L.
 2019
 29 S2 p. S702-S703
 artikel
86 P.3.01 The assessment of dynamic balance in people with multiple sclerosis Paulėkas, E.
 2019
 29 S2 p. S678
 artikel
87 P.2.12 The effect of chronic stress and concomitant cannabis exposure on behaviour and adult hippocampal neurogenesis in mice Rusznák, K.
 2019
 29 S2 p. S663
 artikel
88 P.3.19 The effects of cannabidiol on cerebral blood flow and its relationship to memory: an arterial spin labelling study Green, S.
 2019
 29 S2 p. S693
 artikel
89 P.3.13 The essential amino acid levels in drug-naïve first-episode psychosis Garip, B.
 2019
 29 S2 p. S688
 artikel
90 P.2.15 The NMDA antagonist memantine attenuates the okadaic acid (ICV) induced neurotoxicity in rats Chighladze, M.
 2019
 29 S2 p. S665-S666
 artikel
91 P.3.02 Theory of mind and intrinsic functional connectivity in early onset psychosis: Effects of age and impact on symptoms Simorte, D. Ilzarbe
 2019
 29 S2 p. S678-S679
 artikel
92 P.3.10 The role of CYP2D6 gene in treatment resistant schizophrenia and the effectiveness of treatment resistant schizophrenia Sosin, D.
 2019
 29 S2 p. S685-S686
 artikel
93 P.2.11 The role of the E3 ubiquitin ligase Cullin 3 in brain development and neurodevelopmental disorders Morandell, J.
 2019
 29 S2 p. S662-S663
 artikel
94 P.3.05 Thiol/disulphide homeostasis in bipolar depression and unipolar depression Erzin, G.
 2019
 29 S2 p. S681-S682
 artikel
95 P.1.01 Time-dependent progression of tauopathy and disruption of synaptic proteins in the PS19 P301S transgenic mouse Francois, A.
 2019
 29 S2 p. S632-S633
 artikel
96 P.3.21 Total sleep deprivation with sleep phase advance in treatment-resistant depression: Correlates of clinical response Kurczewska, E.
 2019
 29 S2 p. S694-S695
 artikel
97 P.2.25 Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia Milosavljević, F.
 2019
 29 S2 p. S672-S673
 artikel
98 P.2.04 Trauma-exposed methyl-CpG binding protein 2 mutant mice: A new animal model for post-traumatic stress disorder Cosentino, L.
 2019
 29 S2 p. S657-S658
 artikel
99 P.4.06 Treatment with clozapine and olanzapine and cardiac changes in patients with schizophrenia: An MRI study Osimo, E.F.
 2019
 29 S2 p. S704-S705
 artikel
100 P.1.06 TRKB receptor interaction with postsynaptic density proteins (PSD93 and PSD95) in the mechanism of antidepressants Fred, S.M.
 2019
 29 S2 p. S636-S637
 artikel
101 P.1.27 Unravelling the differential role of FKBP51 (FK506 Binding Protein 5) isoforms in different cellular pathways Martinelli, S.
 2019
 29 S2 p. S652-S653
 artikel
102 P.3.27 Ventral anterior cingulate glutamatergic disbalance in major depressive disorder depends on symptom severity Colic, L.
 2019
 29 S2 p. S699-S700
 artikel
103 P.3.15 White matter architecture in major depression with anxious distress symptoms Heij, J.
 2019
 29 S2 p. S690
 artikel
104 S.01.02 Drug discovery: Designing the ideal opioid Kieffer, B.L.
 2019
 29 S2 p. S632
 artikel
105 S.03.02 Oxidative stress in schizophrenia pathogenesis Do, K.Q.
 2019
 29 S2 p. S677-S678
 artikel
106 S.01.01 Studying autism spectrum disorders in a mouse Novarino, G.
 2019
 29 S2 p. S631-S632
 artikel
                             106 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland